EVIDENCE Meta-Analysis: Evaluating Minimal Residual Disease As an Intermediate Clinical Endpoint for Multiple Myeloma
BLOOD（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined